bioequivalence
Sign in to savethumb|right|335px|A bioequivalency profile comparison of 150 mg extended-release bupropion as produced by [[Impax Laboratories for Teva and Biovail for GlaxoSmithKline]]
Wikidata facts
- Instance of
- quality
Show 1 more fact
- Commons category
- Bioequivalence
Sources (2)
via Wikidata · CC0
~11 min read
Encyclopedic overview
11 sectionsContents
- Bioequivalence
- Regulatory definition
- The World Health Organization
- Australia
- Europe
- United States
- China
- Bioequivalence issues
- See also
- References
- External links
thumb|right|335px|A bioequivalency profile comparison of 150 mg extended-release bupropion as produced by [[Impax Laboratories for Teva and Biovail for GlaxoSmithKline]]
Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same.
Excerpted from Wikipedia’s “bioequivalence” article, available under the CC BY-SA 4.0 licence.